⌘K

Login Start Free

Home/Filings/4/0001441844-11-000023

4//SEC Filing

MCKINNEY ROBERT A 4

Accession 0001441844-11-000023

CIK 0000835887other

View on SEC.gov Company Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 11:27 AM ET

Size

4.4 KB

Accession

0001441844-11-000023

Insider Transaction Report

Form 4

Period: 2011-06-17

PROGENICS PHARMACEUTICALS INCPGNX

MCKINNEY ROBERT A

Chief Financial Officer

Transactions

Sale
Common Stock
2011-06-17$7.50/sh−3,000$22,500→ 42,444 total

Footnotes (1)

[F1]Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1

filerCIK 0001257410

Filing Metadata

Form type: 4
Filed: Jun 19, 8:00 PM ET
Accepted: Jun 20, 11:27 AM ET
Size: 4.4 KB

View on SEC.gov